NCT01880827View on ClinicalTrials.gov

Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

January 31, 2016

Conditions
Type 2 DiabetesObesity
Interventions
PROCEDURE

Roux-en-Y

Subjects in the intervention group will be divided into two consecutive surgical groups, RYGB or SG. After the surgery, subjects are controlled in hospital ward for approximately three days.

DRUG

GIP-infusion

Blood flow and volume during infusion

DRUG

GLP-1

Blood flow and volume during infusion

DRUG

MMS

Blood flow and volume after meal solution

PROCEDURE

Sleeve gastrectomy

as in RYGS group

Trial Locations (1)

20540

Turku univercity hospital, PET center, Turku

All Listed Sponsors
collaborator

Lund University

OTHER

lead

Turku University Hospital

OTHER_GOV

NCT01880827 - Splanchnic Blood Redistribution After Incretin Hormone Infusion and Obesity Surgery | Biotech Hunter | Biotech Hunter